2011
DOI: 10.1016/j.ijpharm.2011.03.017
|View full text |Cite
|
Sign up to set email alerts
|

α-Glucosyl hesperidin induced an improvement in the bioavailability of pranlukast hemihydrate using high-pressure homogenization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 20 publications
(7 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…According to the biopharmaceutical classification system (BCS) [19,20], PRS was classified as a low solubility/low permeability drug (BCS class IV). There were several formulation studies to improve the dissolution profile of PRS HH by applying formulation technologies [21][22][23]. However, it has been challenging to increase the bioavailability of PRS.…”
Section: Dissolution Testsmentioning
confidence: 99%
“…According to the biopharmaceutical classification system (BCS) [19,20], PRS was classified as a low solubility/low permeability drug (BCS class IV). There were several formulation studies to improve the dissolution profile of PRS HH by applying formulation technologies [21][22][23]. However, it has been challenging to increase the bioavailability of PRS.…”
Section: Dissolution Testsmentioning
confidence: 99%
“…Furthermore, nanocomposite formation with these functional food additives using a wet milling process can create nanoparticles from poorly soluble compounds as effectively as high-pressure homogenization. 50 Therefore, Rutin-G may help to create highly dispersed FA nanoparticles <100 nm, thus forming nanocomposites with FA. Nanoparticles usually exhibit strong aggregation due to their high surface energy and a large specific surface area, resulting in low solubility and absorption.…”
Section: ■ Materials and Methodsmentioning
confidence: 99%
“…noted that hesperidin inhibits fructose's absorption for Caco-2 cells [55]. Regarding to nanotechnology applied to cancer treatment, some studies have demonstrated the higher permeability of hesperidin nanoparticles to Caco-2 cells [10,53].…”
Section: Cytotoxicity Assaymentioning
confidence: 99%
“…Thus, the improvement of the physicochemical properties of hesperidin through the design of innovative drug delivery carriers to overcome such limitations appears as an important tool. Along these lines, since hesperidin have demonstrated cytotoxicity activity both in vitro and in vivo methodologies [6][7][8][9][10][11][12], nanoencapsulation emerge as a tool for the secure, sustained, and efficient release of hesperidin as cancer treatment via oral administration. Nanoparticles have been successfully used to improve the oral bioavailability of natural compounds [13].…”
Section: Introductionmentioning
confidence: 99%